文献速递主动脉疾病

结缔组织病与退行性主动脉瘤开放分支移植物重建的10年机构经验

A 10-year institutional experience with open branched graft reconstruction of aortic aneurysms in connective tissue disorders versus degenerative disease.
PubMed 文献 · J Vasc Surg · 2017-06-22

OBJECTIVE: Aortic reconstruction for complex thoracoabdominal aortic aneurysms (TAAAs) can be challenging, especially in patients with connective tissue disorders (CTDs) in whom tissue fragility is a major concern.…

要点

  • 结缔组织病患者围手术期死亡率10%与退行性病变组6%相似(P=.40)。
  • 结缔组织病患者分支移植物通畅率0%丢失,优于退行性病变组的7.8%(P=.005)。
  • 结缔组织病患者新发主动脉瘤(21%)和非主动脉瘤(14%)风险高于退行性病变组(7%和4%,P=.02)。

核心结论

  • 结缔组织病患者接受开放分支移植物重建的结局与退行性病变患者相当,分支移植物通畅率更优,围手术期死亡和并发症风险相似。
  • 两群体均可安全进行开放分支移植物重建,但结缔组织病患者需持续监测新发动脉瘤。

研究设计与样本

  • 比较两组围手术期发病率、死亡率、中期移植物通畅率及新发动脉瘤。

主要发现

  • 结缔组织病患者更年轻(39±1.9 vs 68±1.0岁;P<.001),合并症更少(高血压、慢性阻塞性肺疾病、冠心病;P<.05),主动脉夹层比例更高(55% vs 16%;P<.001),胸主动脉瘤比例更高(90% vs 60%;P=.003)。
  • 围手术期死亡率(结缔组织病10%[n=3] vs 退行性病变6%[n=6];P=.40)和任何并发症(62% vs 55%;P=.47)两组相似。
  • 中位随访14.5个月(四分位距6.5-43.9个月),结缔组织病患者新发主动脉瘤(21%)和非主动脉瘤(14%)风险高于退行性病变组(7%和4%;P=.02)。
  • 分支移植物通畅丢失在结缔组织病组为0/99(0%),退行性病变组为13/167(7.8%)(P=.005)。
  • 分支移植物通畅丢失最常见于左肾动脉旁路移植(77%),且临床无症状(当前肌酐1.77±0.13 mg/dL vs 术前1.41±0.25 mg/dL;P=.22)。

临床怎么用

  • 开放分支移植物重建可用于结缔组织病和退行性主动脉瘤患者,围手术期死亡率低。
  • 结缔组织病患者术后需持续监测新发主动脉和非主动脉瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Aortic reconstruction for complex thoracoabdominal aortic aneurysms (TAAAs) can be challenging, especially in patients with connective tissue disorders (CTDs) in whom tissue fragility is a major concern. Branched graft reconstruction is a more complex operation compared with inclusion patch repair of the aorta but is frequently necessary in patients with CTDs or other pathologies because of anatomic reasons. We describe our institutional experience with open branched graft reconstruction of aortic aneurysms and compare outcomes for patients with CTDs vs degenerative pathologies. METHODS: We retrospectively analyzed all patients undergoing open aortic reconstruction using branched grafts at our institution between July 2006 and December 2015. Postoperative outcomes, including perioperative morbidity and mortality, midterm graft patency, and the development of new aneurysms, were compared for patients with CTD vs degenerative disease. RESULTS: During the 10-year study period, 137 patients (CTD, 29; degenerative, 108) underwent aortic repair with branched graft reconstruction. CTD patients were significantly younger (39 ± 1.9 vs 68 ± 1.0 years; P < .001) and had fewer comorbidities (hypertension, chronic obstructive pulmonary disease, coronary artery disease; P < .05) but a higher prevalence of aortic dissections (55% vs 16%; P < .001) and aneurysms involving the thoracic aorta (90% vs 60%; P = .003) than patients with degenerative disease. Perioperative mortality (CTD: 10% [n = 3] vs degenerative: 6% [n = 6]; P = .40) and any complication (62% vs 55%; P = .47) were similar between groups. At a median follow-up time of 14.5 months (interquartile range: 6.5, 43.9 months), CTD patients were more likely to develop both new aortic (21%) and nonaortic (14%) aneurysms compared with the degenerative group (7% and 4% for aortic and nonaortic aneurysms, respectively; P = .02). Loss of branch graft patency occurred in 0 of 99 grafts (0%) in CTD patients and in 13 of 167 grafts (7.8%) in degenerative disease patients (P = .005). Loss of branch graft patency occurred most commonly in left renal artery bypass grafts (77%) and was clinically asymptomatic (creatinine: 1.77 ± 0.13 mg/dL currently vs 1.41 ± 0.25 preoperatively; P = .22). CONCLUSIONS: CTD patients with aortic aneurysms who undergo open branched graft reconstruction have reasonable outcomes compared with patients with degenerative pathology, including better branched graft patency and a similar risk of perioperative mortality and complications. Open repair of aortic aneurysms with branched graft reconstruction can be performed safely in both populations with low perioperative mortality, but ongoing surveillance is critical for the detection of new aneurysms, especially among patients with CTD.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hicks CW, Lue J, Glebova NO, et al. A 10-year institutional experience with open branched graft reconstruction of aortic aneurysms in connective tissue disorders versus degenerative disease. J Vasc Surg. 2017. PMID: 28648480. doi:10.1016/j.jvs.2017.03.451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。